1. Home
  2. SME IPO
  • Hamps Bio Limited IPO
hamps bio ltd logo

Hamps Bio IPO

  • Status: Closed
  • RHP:
  • ₹ 102,000 / 2000 shares

    Minimum Investment

IPO Details

  • Open Date

    13 Dec 2024

  • Close Date

    17 Dec 2024

  • IPO Price Range

    ₹ 51

  • IPO Size

    ₹ 6.22 Cr

  • Listing Exchange

    BSE SME

  • Listing Date

    20 Dec 2024

With just a few clicks, Invest in IPOs!

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Objective Financials SWOT FAQ Contacts

IPO Timeline

Hamps Bio IPO Subscription Status

Last Updated: 17 December 2024 6:02 PM by 5Paisa

Hamps Bio IPO is set to open on 13 December 2024 and will close on 17 December 2024. Hamps Bio specializes in the marketing and distribution of pharmaceutical products, including tablets, syrups, capsules, injectables, and nutritional supplements.
 
The IPO is a fresh issue of  0.12 Cr shares aggregating to ₹6.22 Cr. The price is set at ₹51 per share and the lot size is 2,000 shares. 

The allotment is scheduled to be finalised on 18 December 2024. It will go public on BSE SME, with a tentative listing date of 20 December 2024.

Marwadi Chandarana Intermediaries Brokers Pvt. Ltd is the book running lead manager, while Big Share Services Pvt Ltd is the registrar. 

Hamps Bio IPO Size

Types Size
Total IPO Size ₹6.22 Cr.
Offer For Sale -
Fresh Issue ₹6.22 Cr.

 

Hamps Bio IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 ₹102,000
Retail (Max) 1 2000 ₹102,000
HNI (Min) 2 4000 ₹204,000

 

Hamps Bio IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)*
NII (HNI) 758.27 5,79,000 43,90,36,000 2,239.08
Retail 1,342.04 5,79,000 77,70,42,000 3,962.91
Total** 1,057 11,58,001 1,22,40,12,000 6,242.46

 

The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

1. Purchase of plant & machinery for FMCG division
2. Enhancing the visibility and awareness of the brand
3. General corporate purposes
 

Hamps Bio Limited has emerged as a key player in the marketing and distribution of pharmaceutical products, including tablets, syrups, capsules, injectables, and nutritional supplements. The company operates a robust network with over 50 distributors and partners with leading e-commerce platforms such as Amazon (US, Canada, EU), Flipkart, and Jio Mart. Its pharmaceutical products are available in 8 states and union territories across India, while its freeze-dried and frozen offerings reach 22 domestic locations and 6 international markets.

Hamps Bio operates two main business verticals: Pharmaceuticals under the "Hamps" brand and freeze-dried and frozen FMCG products under the "FzyEzy" brand, catering to both B2B and B2C markets. With a portfolio of over 180 products and a dedicated team of 78 employees as of October 2024, Hamps Bio stands out due to its expert leadership, extensive product range, strong distribution network, and growing geographical footprint. This trusted brand identity positions Hamps Bio as a leader in domestic and global markets, driving growth and innovation.
 

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY24 FY23 FY22
Revenue 6.50 5.58 5.34
EBITDA 1.18 0.87 0.62
PAT 0.50 0.36 0.12
Particulars (in Rs. Crores) FY24 FY23 FY22
Total Assets 5.15 3.96 3.64
Share Capital 1.96 1.50 1.50
Total Borrowings 1.05 1.74 2.04
Particulars (in Rs. Crores) FY24 FY23 FY22
Net Cash Generated From / (used in) operating activities -0.29 1.23 0.33
Net Cash Generated From / (used in) investing activities -0.37 -0.75 0.51
Net Cash Generated From / (used in) financing activities 0.67 -0.48 -0.94
Net Increase (Decrease) In Cash And Cash Equivalents - - -0.10

Strengths

1. Strong leadership with extensive industry experience.
2. Wide range of over 180 diverse products.
3. Established distribution network across domestic and international markets.
4. Trusted brands, "Hamps" and "FzyEzy," with customer loyalty.
5. Presence on leading e-commerce platforms ensures broad customer reach.
 

Risks

1. Dependence on third-party distributors for product availability.
2. Limited presence in certain domestic and international markets.
3. High competition in pharmaceutical and FMCG segments.
4. Susceptibility to regulatory changes in the healthcare industry.
5. Seasonal demand fluctuations for freeze-dried and frozen products.

Will You Apply for Hamps Bio IPO?

Yes No Maybe

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Hamps Bio IPO opens from 13 December to 17 December 2024.

The size of Hamps Bio IPO is ₹6.22 Cr.

The price of Hamps Bio IPO is fixed at ₹51 per share. 

To apply for Hamps Bio IPO, follow the steps given below:

● Login to your 5paisa account and select the issue in the current IPO section    
● Enter the number of lots and the price at which you wish to apply for the Hamps Bio  IPO.    
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    

You will receive a mandate notification to block funds in your UPI app.
 

The minimum lot size of Hamps Bio IPO is 2000 shares and the investment required is ₹102,000.
 

The share allotment date of Hamps Bio IPO is 18 December 2024

The Hamps Bio IPO will be listed on 20 December 2024.

Marwadi Chandarana Intermediaries Brokers Pvt Ltd is the book running lead manager for Hamps Bio IPO.
 

Hamps Bio plans to utilise the raised capital from the IPO for:
1. Purchase of plant & machinery for FMCG division
2. Enhancing the visibility and awareness of the brand
3. General corporate purposes